Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure
Clinical trial NCT03458325 · COMPLETED
Trial details
- NCT number
- NCT03458325
- Sponsor
- scPharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-12
- Primary completion
- 2021-06-24
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.